- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Cortical Reaction.
Displaying page 1 of 1.
EudraCT Number: 2015-005495-19 | Sponsor Protocol Number: RVT-101-2001 | Start Date*: 2016-06-13 | |||||||||||
Sponsor Name:Axovant Sciences Inc. | |||||||||||||
Full Title: A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB). | |||||||||||||
Medical condition: Dementia with Lewy Bodies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2023-000018-16 | Sponsor Protocol Number: OZA22/IM047-048 | Start Date*: 2023-04-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: Effect of ozanimod on meningeal inflammation and glial activation in Multiple Sclerosis: one year phase 4 experimental study | |||||||||||||
Medical condition: Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001054-96 | Sponsor Protocol Number: 000013/BT | Start Date*: 2020-03-19 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: Phase IIb, Placebo-Controlled, Randomized, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB) Single Implantation in Tibial Fracture | |||||||||||||
Medical condition: Tibial fracture considered at risk of DU/NU (based on the combination of risk factors documented to be associated with increased proportion of DU/NU). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Ongoing) DE (Prematurely Ended) HU (Ongoing) PL (Ongoing) ES (Ongoing) CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001573-28 | Sponsor Protocol Number: Uni-Koeln-320 | Start Date*: 2007-11-26 |
Sponsor Name:Universität zu Köln | ||
Full Title: Prevent: Secondary Prevention of Schizophrenia. A randomized controlled trial. | ||
Medical condition: Persons at risk of being prodromally symptomatic of psychosis (PAR) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006003-15 | Sponsor Protocol Number: E2007-M065-505 | Start Date*: 2021-12-27 | |||||||||||
Sponsor Name:Eisai Korea Inc. | |||||||||||||
Full Title: Post-Marketing Surveillance of Fycompa in Korean Patients | |||||||||||||
Medical condition: Partial-onset seizure and primary generalized tonic-clonic seizure | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004129-89 | Sponsor Protocol Number: Motor-Neuromod_01, Part I-III | Start Date*: 2005-09-19 |
Sponsor Name:Universitätsklinikum Münster | ||
Full Title: Potentiation of procedural motor learning by pharmacological neuromodulation and brain stimulation | ||
Medical condition: Healthy volunteers Patients in the chronic stage (> 1 year) after stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-002038-36 | Sponsor Protocol Number: 11018 | Start Date*: 2007-02-27 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson’s disease dementia or dementia with Lewy Bodies | |||||||||||||
Medical condition: Patients with Parkinson’s disease dementia or dementia with Lewy Bodies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) GB (Completed) AT (Completed) IT (Completed) DE (Completed) FR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004509-30 | Sponsor Protocol Number: 012020 | Start Date*: 2021-05-13 | |||||||||||
Sponsor Name:INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON | |||||||||||||
Full Title: A prospective structural, diffusion and connectomics MRI study on migraine patients treated with Fremanezumab | |||||||||||||
Medical condition: MIGRAINE | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-006067-28 | Sponsor Protocol Number: CST103/CST107-CLIN-011 | Start Date*: 2022-01-10 | ||||||||||||||||||||||||||
Sponsor Name:CuraSen Therapeutics, Inc. | ||||||||||||||||||||||||||||
Full Title: A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 co-administered with CST-107 on the Central Nervous System in Subjects with Neur... | ||||||||||||||||||||||||||||
Medical condition: Patients with Parkinson’s Disease with REM sleep behaviour disorder, Mild Cognitive Impairment, Dementia with Lewy Bodies and Parkinson’s Disease Dementia. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002858-36 | Sponsor Protocol Number: FIM-DON-2017-01 | Start Date*: 2018-09-19 | |||||||||||
Sponsor Name:FIMABIS Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina Y Salud | |||||||||||||
Full Title: STUDY OF THE EFFECTIVENESS AND CEREBRAL REORGANIZATION AFTER TREATMENT COMBINED WITH DONEPEZILO, INTENSIVE REHABILITATION AND TRANSCRANEAL DIRECT CURRENT STIMULATION IN POSTSTROKE CHRONIC AFASIA | |||||||||||||
Medical condition: Chronic poststroke aphasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000370-27 | Sponsor Protocol Number: COR388-010-UK | Start Date*: 2019-10-24 | |||||||||||
Sponsor Name:Cortexyme, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled Study of COR388 HCl in Subjects with Alzheimer’s Disease | |||||||||||||
Medical condition: Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.